BBDC vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals significant concerns, with a Piotroski F-Score of just 2/9 indicating weak financial health. Despite a high dividend yield of 11.27%, the unsustainable 108.33% payout ratio and bearish insider activity raise red flags. While profitability metrics like operating margin and ROE are strong relative to peers, elevated debt (D/E of 1.39) and deteriorating earnings momentum in recent quarters undermine confidence. The stock trades below intrinsic value estimates ($17.34) and slightly above the Graham Number ($15.40), but structural risks outweigh valuation appeal.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
BBDC vs JPM: Head-to-Head Comparison
This page compares Barings BDC, Inc. (BBDC) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.